Active A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With ARPKD United States Browse Job
Active A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With ARPKD Browse Job
Active An international multicenter registry study on autosomal recessive polycystic kidney disease (ARPKD) – ARegPKD Multiple Locations Browse Job
